UK COUNTRY FOCUS
the design of buildings that can be radically adapted to meet changing needs at a minimum cost. Companies such as Penoyre & Prasad, who developed ‘Heart of Hounslow’ demonstrate this.
E-HEALTH AND INFORMATICS UK technology companies have a strong track record of working with both the NHS and private-sector providers to establish secure Electronic Patient Record (EPR) systems that assist in delivering improved outcomes for patients and allow them a greater degree of control over their care. EPR systems have the potential to bring huge benefits to patients and are being implemented in health systems across the world. EPRs can speed up clinical communication, reduce the number of errors and assist doctors in diagnosis and treatment. They also enable patients to exercise a greater degree of control over their own healthcare, and provide electronic data with the potential to improve the quality of healthcare audit and research. To achieve the highest possible level of performance and to maximise the benefits that e-health can deliver, it is essential that ICT, communications and networks are fully integrated into the infrastructure development programme, and that their impact is factored into masterplanning, building design, utilisation and management. This strategic planning and development is a special characteristic of the UK’s approach to infrastructure development.
LIFE SCIENCES INNOVATION The UK is acknowledged as having one of the world’s largest and most innovative Life Sciences communities. Comprising pharmaceuticals, biotechnology and medical technology, the UK attracts almost 10% of the world’s pharmaceutical R&D funding and leads Europe with its biopharmaceutical pipeline. Pharmaceuticals originating in the UK account for 16% of the sales of the world’s top 100 medicines and the UK medical technology sector includes some of the most innovative companies globally. The UK is home to two of the world’s leading pharmaceutical companies, GlaxoSmithKline and AstraZeneca. All of the top ten global pharmaceutical companies have either research or manufacturing facilities in the UK. Smith and Nephew and Smiths Medical are world- leaders in medical devices and GE Medical is headquartered in the UK, the only division of GE to be based outside of the USA. The success of UK Life Sciences companies is evidence of the depth of the country’s pool of talent and the strength of its research base. Four of the world’s top ten universities are in the UK and it is rated as the best European location for bioscience, healthcare/medical and clinical research. In the last ten years alone, eight British scientists have been awarded the Nobel Prize for Medicine. This pre-eminence in both basic and translational research enables the UK to lead the way in many emerging areas of medical science that promise to transform healthcare in the 21st century, such as regenerative medicine and personalised/stratified therapeutics. At Arab Health 2012, UKTI worked with key UK trade
associations and networks ABHI, Medilink UK, and Gambica, to organise a UK pavilion with 200 world-class UK expor ters of medical technology including medical devices, single-use devices, surgical instruments, wound care, diagnostics, patient monitoring and, laboratory technology.
MEDICAL TECHNOLOGY AND TELEMEDICINE The UK is at the forefront of medical technology, where the partnership between UK industry, academia and the NHS enables discovery and innovation to move into mainstream healthcare. UK medical technology companies are well placed to contribute to healthcare systems through the provision of equipment and
www.lifesciencesmagazines.com
services needed for state-of- the-art facilities, from point-of-care in the community setting to major centres of excellence. The UK’s offering includes the development and implementation of telemedicine technologies that promise to revolutionise treatment and health management in the 21st century. Companies like Tunstall have delivered solutions that not only improve patient experiences and outcomes, but also boost efficiency. Moreover, initiatives such as the NHS Whole System Demonstrator
programme, the largest randomised controlled trial of telemedicine and telecare in the world, give the UK a world-leading position in implementing and evaluating telehealth solutions. UK
The Hamlyn Centre for Robotic Surgery, courtesy of Imperial College London
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84